TTM Technologies Reports Q2 2024 Net Sales of $605.1M

TTM Technologies, Inc. has reported its second quarter 2024 results, with net sales reaching $605.1 million. The company's GAAP net income for the same period was $26.4 million, or $0.25 per diluted share. On a non-GAAP basis, the net income stood at $40.1 million, or $0.39 per diluted share.

Compared to the second quarter of 2023, TTM's net sales have increased from $546.5 million to $605.1 million. Similarly, the GAAP operating income rose from $21.4 million to $39.0 million. The GAAP net income also saw a significant increase from $6.8 million, or $0.07 per diluted share, to $26.4 million, or $0.25 per diluted share.

On a non-GAAP basis, the net income for the second quarter of 2024 was $40.1 million, up from $33.0 million in the same period of 2023. Additionally, the adjusted EBITDA for the second quarter of 2024 was $84.6 million, or 14.0% of sales, compared to $74.7 million, or 13.7% of sales, for the second quarter of 2023.

The company also repurchased 1.39 million shares of common stock for $25.1 million at an average price of $18.09 per share during the second quarter of 2024. TTM Technologies, Inc. anticipates closing the refinancing of $346.5 million of a senior secured term loan at an interest rate of SOFR + 2.25% on August 1, 2024, which is 50 basis points lower than the previous term B loans issued in May 2023.

Looking ahead, for the third quarter of 2024, TTM projects revenues in the range of $580 million to $620 million and non-GAAP net income in the range of $0.37 to $0.43 per diluted share.

Following these announcements, the company's shares moved -5.0%, and are now trading at a price of $19.71. For the full picture, make sure to review TTM Technologies's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS